These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Continuous home ambulatory intravenous inotropic drug therapy in severe heart failure: safety and cost efficacy. Sindone AP; Keogh AM; Macdonald PS; McCosker CJ; Kaan AF Am Heart J; 1997 Nov; 134(5 Pt 1):889-900. PubMed ID: 9398101 [TBL] [Abstract][Full Text] [Related]
26. Acute heart failure with dyspnoea: initial treatment. Furosemide and trinitrine, despite the lack of a proven survival benefit. Prescrire Int; 2011 Jun; 20(117):156-60. PubMed ID: 21678708 [TBL] [Abstract][Full Text] [Related]
27. A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus. Farmakis D; Agostoni P; Baholli L; Bautin A; Comin-Colet J; Crespo-Leiro MG; Fedele F; García-Pinilla JM; Giannakoulas G; Grigioni F; Gruchała M; Gustafsson F; Harjola VP; Hasin T; Herpain A; Iliodromitis EK; Karason K; Kivikko M; Liaudet L; Ljubas-Maček J; Marini M; Masip J; Mebazaa A; Nikolaou M; Ostadal P; Põder P; Pollesello P; Polyzogopoulou E; Pölzl G; Tschope C; Varpula M; von Lewinski D; Vrtovec B; Yilmaz MB; Zima E; Parissis J Int J Cardiol; 2019 Dec; 297():83-90. PubMed ID: 31615650 [TBL] [Abstract][Full Text] [Related]
28. [Value of aldosterone receptor blockade in diuretic therapy of patients with chronic heart failure]. Christ M; Ludwig N; Maisch B Herz; 2002 Mar; 27(2):135-49. PubMed ID: 12025459 [TBL] [Abstract][Full Text] [Related]
29. Therapeutic adjustments in stage D heart failure: challenges and strategies. Joyce E; Nohria A Curr Heart Fail Rep; 2015 Feb; 12(1):15-23. PubMed ID: 25391351 [TBL] [Abstract][Full Text] [Related]
30. Diagnostic and therapeutic approach to acute decompensated heart failure. Kapoor JR; Perazella MA Am J Med; 2007 Feb; 120(2):121-7. PubMed ID: 17275448 [TBL] [Abstract][Full Text] [Related]
31. Use of Inotropic Agents in Treatment of Systolic Heart Failure. Tariq S; Aronow WS Int J Mol Sci; 2015 Dec; 16(12):29060-8. PubMed ID: 26690127 [TBL] [Abstract][Full Text] [Related]
32. Rational use of inotropic therapy in heart failure. Felker GM; O'Connor CM Curr Cardiol Rep; 2001 Mar; 3(2):108-13. PubMed ID: 11177666 [TBL] [Abstract][Full Text] [Related]
33. [Palliative inotrope therapy in advanced heart failure: organization and management]. Gorni G; Correale M; Nodari S; Sinagra G G Ital Cardiol (Rome); 2020 Apr; 21(4):296-302. PubMed ID: 32202562 [TBL] [Abstract][Full Text] [Related]
34. Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations. Klein L; O'Connor CM; Gattis WA; Zampino M; de Luca L; Vitarelli A; Fedele F; Gheorghiade M Am J Cardiol; 2003 May; 91(9A):18F-40F. PubMed ID: 12729848 [TBL] [Abstract][Full Text] [Related]
35. Infections, Arrhythmias, and Hospitalizations on Home Intravenous Inotropic Therapy. Acharya D; Sanam K; Revilla-Martinez M; Hashim T; Morgan CJ; Pamboukian SV; Loyaga-Rendon RY; Tallaj JA Am J Cardiol; 2016 Mar; 117(6):952-6. PubMed ID: 26810859 [TBL] [Abstract][Full Text] [Related]
36. Intermittent positive inotrope infusion in the management of end-stage, low-output heart failure. Levine BS J Cardiovasc Nurs; 2000 Jul; 14(4):76-93. PubMed ID: 10902105 [TBL] [Abstract][Full Text] [Related]
38. "I Just Feel Like I Always Did": Inotropic Dependency at End of Life. Latimer A; Pope ND; McFarlin JM Am J Hosp Palliat Care; 2020 Jul; 37(7):497-502. PubMed ID: 31714150 [TBL] [Abstract][Full Text] [Related]